U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H9N3O2.HNO3
Molecular Weight 194.146
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CREATINE NITRATE

SMILES

O[N+]([O-])=O.CN(CC(O)=O)C(N)=N

InChI

InChIKey=MBSCHHMCRIMBDZ-UHFFFAOYSA-N
InChI=1S/C4H9N3O2.HNO3/c1-7(4(5)6)2-3(8)9;2-1(3)4/h2H2,1H3,(H3,5,6)(H,8,9);(H,2,3,4)

HIDE SMILES / InChI

Molecular Formula HNO3
Molecular Weight 63.0128
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C4H9N3O2
Molecular Weight 131.1332
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Creatine is an amino acid that occurs in vertebrate tissues and in urine. It is synthesized mainly in the liver from three different amino acids: arginine, glycine, and methionine. In skeletal muscles, which store 95% of it, creatine generally occurs as phosphocreatine. The rest is stored in the brain, heart, and testes. Creatine functions as part of the cell's energy shuttle. It is excreted as creatinine in the urine.

Approval Year

PubMed

PubMed

TitleDatePubMed
Acute quadriceps compartment syndrome and rhabdomyolysis in a weight lifter using high-dose creatine supplementation.
2000 Mar-Apr
A dimeric creatine kinase from a sponge: implications in terms of phosphagen kinase evolution.
2000 May
Phosphorylation-dependent alteration in myofilament ca2+ sensitivity but normal mitochondrial function in septic heart.
2001 Feb
Parkinsonism and neck extensor myopathy: a new syndrome or coincidental findings?
2001 Feb
The three-dimensional structure of cytosolic bovine retinal creatine kinase.
2001 Feb
Altered activities of rat brain metabolic enzymes caused by pentylenetetrazol kindling and pentylenetetrazol--induced seizures.
2001 Feb
Myopathic form of very-long chain acyl-coa dehydrogenase deficiency: evidence for temperature-sensitive mild mutations in both mutant alleles in a Japanese girl.
2001 Feb
Brain proton magnetic resonance spectroscopy and imaging in children exposed to cocaine in utero.
2001 Feb
Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation.
2001 Feb
Mouse model of myocardial remodelling after ischemia: role of intercellular adhesion molecule-1.
2001 Feb 1
The crystal structure of the fab fragment of the monoclonal antibody MAK33. Implications for folding and interaction with the chaperone bip.
2001 Feb 2
Deterioration in renal function associated with fibrate therapy.
2001 Jan
Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.
2001 Jan
Exercise training increases creatine kinase capacity in canine myocardium.
2001 Jan
Creatine supplementation affects muscle creatine during energy restriction.
2001 Jan
Treatment of exercise-induced muscle injury via hyperbaric oxygen therapy.
2001 Jan
Effect of elbow joint angle on the magnitude of muscle damage to the elbow flexors.
2001 Jan
Leukocyte filtration in the early reperfusion phase on cardiopulmonary bypass reduces myocardial injury.
2001 Jan
Effects of EGF receptor ligands on fetal ovine myoblasts.
2001 Jan
Pretreatment of human myocardium with adenosine.
2001 Jan
Proton MR spectroscopy in patients with acute temporal lobe seizures.
2001 Jan
Magnetization transfer imaging and proton MR spectroscopy in the evaluation of axonal injury: correlation with clinical outcome after traumatic brain injury.
2001 Jan
Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas.
2001 Jan
Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction.
2001 Jan
Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis.
2001 Jan
Direct activation of mitochondrial K(ATP) channels mimics preconditioning but protein kinase C activation is less effective in middle-aged rat hearts.
2001 Jan
Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease.
2001 Jan
Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies.
2001 Jan 20
Expression and purification of polyhistidine-tagged firefly luciferase in insect cells--a potential alternative for process scale-up.
2001 Jan 23
Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction.
2001 Jan 6
Dysarthria as the leading symptom of hypothyroidism.
2001 Jan-Feb
Patents
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:10:32 GMT 2023
Edited
by admin
on Fri Dec 15 17:10:32 GMT 2023
Record UNII
1XGV09LL9X
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CREATINE NITRATE
Common Name English
GLYCINE, N-(AMINOIMINOMETHYL)-N-METHYL-, NITRATE (1:1)
Common Name English
CREATINE, COMPD. WITH HNO3
Common Name English
GLYCINE, N-(AMINOIMINOMETHYL)-N-METHYL-, MONONITRATE
Common Name English
Code System Code Type Description
PUBCHEM
25231507
Created by admin on Fri Dec 15 17:10:32 GMT 2023 , Edited by admin on Fri Dec 15 17:10:32 GMT 2023
PRIMARY
CAS
89695-59-0
Created by admin on Fri Dec 15 17:10:32 GMT 2023 , Edited by admin on Fri Dec 15 17:10:32 GMT 2023
PRIMARY
FDA UNII
1XGV09LL9X
Created by admin on Fri Dec 15 17:10:32 GMT 2023 , Edited by admin on Fri Dec 15 17:10:32 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY